Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support  Ranjit John, MD, James W. Long, MD, H. Todd Massey, MD, Bartley P. Griffith, MD, Benjamin C. Sun, MD, Alfred J. Tector, MD, O. Howard Frazier, MD, Lyle D. Joyce, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 4, Pages 932-939 (April 2011) DOI: 10.1016/j.jtcvs.2010.03.046 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Levitronix CentriMag ventricular assist system (Levitronix LLC, Waltham, Mass). A, Single-use blood pump. B, Assembled device, consisting of bearingless motor supporting pump. C, Portable primary drive console. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 932-939DOI: (10.1016/j.jtcvs.2010.03.046) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Thirty-day survival. RVAD, Right ventricular assist device; PCCS, postcardiotomy cardiogenic shock; MI, myocardial infarction. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 932-939DOI: (10.1016/j.jtcvs.2010.03.046) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions